Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2023-06-05 00:00:00 ET · period of report 2023-06-02 · accession 0001437749-23-016659 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-05 | 2023-06-02 | LMAT | Ross Bridget A | Dir | S - Sale+OE | $64.24 | -5,000 | 1,169 | -81% | -$321.2K |
| D | 2023-06-05 | 2023-06-02 | LMAT | Ross Bridget A | Dir | M - OptEx | $37.29 | +5,000 | 6,169 | +428% | +$186.4K |
| D | 2023-06-05 | 2023-06-02 | LMAT | Ross Bridget A | Dir | M - OptEx | $0.00 | -5,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-02 | S | D | 5,000 | $64.24 | 1,169 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $64.23 to $64.44. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. |
| 2 | Common | Common Stock | 2023-06-02 | M | A | 5,000 | $37.29 | 6,169 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-06-02 | M | D | 5,000 | $0.00 | 0 | D | $37.29 · 2020-04-28 to 2025-04-28 | 5,000 Common Stock |